Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that eventually robs them of the ability to move, speak, eat or breathe. Now, ...
Note: It’s purely MotoGP. Now that we have that clarified, here’s the big breaking news: Yamaha recently declared that it was formally retiring its iconic inline-four "big-bang" M1 – the same platform ...
Actor Eric Dane got real about what it’s like to live with ALS, and candidly discussed on Tuesday the range of emotional and physical repercussions of the devastating diagnosis. The “Euphoria” actor ...
The actor, who publicly announced his diagnosis earlier this year, spoke on a virtual panel with I Am ALS and writers from the NBC drama: "I have no reason to be in a good spirit at any time, on any ...
Eric Dane is sharing everything about his ALS battle — including the emotional toll that the devastating diagnosis has taken on him. The “Euphoria” actor, 53, gave the latest update on his health ...
Dane announced his ALS diagnosis in April. Eric Dane is opening up about his future in acting while living with ALS. During a panel hosted by the I Am ALS organization on Tuesday night, the "Euphoria" ...
Yamaha Motor Co., Ltd. Have confirmed that the YZR-M1 machines will be powered by the V4 engine from the 2026 season onwards. This decision aligns with Yamaha's intentions to transition, underlining ...
Last year’s CFMoto booth at EICMA motorcycle expo in Milan was perhaps the hottest one at the show. At the center of all the excitement was a completely new, state-of-the-art liter-class V4 and a ...
People in certain states in America appear to be more likely than others to develop devastating neurological diseases, a new study has indicated. Lou Gehrig's disease—also known as amyotrophic lateral ...
In March 2024, Kayla Gonzalez started having an odd sensation behind her right kneecap. At first, she didn’t think much of it. Then, the feeling started to spread. Soon, she had weakness in her calf, ...
Despite modern imaging and genetic testing, diagnosing amyotrophic lateral sclerosis (ALS) remains challenging, particularly when distinguishing it from clinically similar neurodegenerative disorders.